|
|
 |
Aeolus Management
John
L. McManus
President/Chief Executive Officer
 Mr.
McManus joined the Company in June 2005 as President; he serves this role
in a greater than 50% employment capacity. Mr. McManus, who received his
degree in business administration from the University of Southern California
in 1986, is the founder and president of McManus Financial Consultants,
Inc., which provides strategic, financial and investor relations advice
to senior managements and boards of directors of public companies, including
advice on mergers and acquisitions. These companies have a combined value
of over $25 billion. In addition, Mr. McManus previously served as Vice
President, Finance and Strategic Planning to Spectrum Pharmaceuticals, Inc.
(NasdaqNM: SPPI) where he had primary responsibility for restructuring Spectrum’s
operations and finances, including the design of strategic and financial
plans to enhance Spectrum’s corporate focus, and leading the successful
implementation of these plans. The implementation of these plans led to
an increase in Spectrum’s market value from $1 million to more than
$125 million at the time of Mr. McManus’ departure.
Brian
J. Day, Ph.D.
Chief Scientific Officer
Dr. Day was appointed Chief Scientific Officer of Aeolus in September 2004.
He is one of the scientific co-founders of Aeolus and an inventor on a majority
of the program’s patents. Dr. Day has extensive training in both pharmacology
and toxicology with over 14 years experience. Since 1994 he has helped guide
the design and synthesis of metalloporphyrins and has discovered a number
of their novel activities in biological systems. Dr. Day has authored over
70 original scientific publications and served as a consultant to biotechnology
companies for over 10 years. He is an active member of a number of scientific
societies including the American Chemical Society, Society for Free Radicals
in Biology and Medicine, and Society of Toxicology, where he served on the
Board of Publications. Dr. Day has been at National Jewish Medical and Research
Center since 1997 and currently is an Associate Professor in the Environmental
and Occupational Health Sciences Division and thus is employed as a consultant
by Aeolus. Michael McManus
Chief Financial Officer
 Mr.McManus
became Chief Accounting Officer, Treasurer and Secretary of Aeolus on June
16, 2005. Mr. McManus, has also served as the Executive Vice President of
McManus Financial Consultants, Inc. (“MFC”) since 1995. MFC
is a leading provider of financial, management and investor relations consulting
and support services to publicly traded companies. From 2001 to 2003, Mr.
McManus also served as Controller and Principal Accounting Officer of Spectrum
Pharmaceuticals, Inc., where he was responsible for restructuring Spectrum’s
accounting and administration functions. Prior to joining MFC, from 1991
to 1995, he worked at Price Waterhouse LLP as an audit manager for healthcare
and financial services companies. Mr. McManus is a retired Certified Public
Accountant and holds a B.S. in Accounting from the University of Southern
California.
|
|
|
